Saturday, March 2, 2024
- Advertisement -spot_img

TAG

BIOPH

Lilly’s blockbuster Mounjaro boosts third quarter results, supply issues persist

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo Acquire...

US FDA declines approval for expanded use of Alnylam’s heart-disease drug

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo ...

Weight-loss drugs fuel boom for firms that fill syringes

Demand soars for self-injection weight-loss drugsObesity market could be worth $100 bln within a decade-analystsContract drugmakers race to expand capacity to fill syringesLONDON, Oct...

Exclusive: Catalent to explore options after Elliot deal-sources

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman ...

Biocon may list biosimilars business by 2025 first half – CEO

An employee of Biocon Ltd works inside the company's research and development centre in Bengaluru, India, October 16, 2015. REUTERS/Abhishek N. Chinnappa/File PhotoHYDERABAD,...

US announces trial payment program for care providers of dementia patients

July 31 (Reuters) - The U.S. government said on Monday it would trial a new payment program for people who provide dementia care coordination...

US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug

LOS ANGELES, July 6 (Reuters) - Eisai (4523.T) and Biogen's (BIIB.O) Leqembi won a coveted standard approval nod from the U.S. Food and Drug...

Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court

WASHINGTON, March 27 (Reuters) - The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc (AMGN.O) to revive patents...

Latest news

- Advertisement -spot_img